Inventor · disambiguated record
Martin Werner Borchsenius Muenzel
Also filed as: MUENZEL MARTIN · MUENZEL MARTIN WERNER BORCHSENIUS
7 granted patents·5 pending applications·5 citations·filing 2015–2024
74Inventor score
Files withNOVO NORDISK AS12
Top patents by PatentIndex Score
12 records- 0187US11767332B2Glucose-sensitive albumin-binding derivativesNOVO NORDISK AS·Filed 2021·Granted Sep 26, 2023·1 cites·3 claims
- 0286US11186595B2Glucose-sensitive albumin-binding derivativesNOVO NORDISK AS·Filed 2018·Granted Nov 30, 2021·3 cites·13 claims
- 0381US12227528B2Glucose-sensitive albumin-binding derivativesNOVO NORDISK AS·Filed 2023·Granted Feb 18, 2025·0 cites·4 claims
- 0481US2025122226A1Glucose-sensitive albumin-binding derivativesNOVO NORDISK AS·Filed 2024·Application pending·0 cites
- 0563US10040839B2Insulin derivatives and the medical uses hereofNOVO NORDISK AS·Filed 2015·Granted Aug 7, 2018·1 cites·48 claims
- 0654US2020283493A1Novel Insulin Derivatives and the Medical Uses HereofNOVO NORDISK AS·Filed 2020·Application pending·0 cites
- 0749US2019010206A1Novel Insulin Derivatives and the Medical Uses HereofNOVO NORDISK AS·Filed 2016·Application pending·0 cites
- 0848US11649269B2Bifunctional compounds comprising insulin peptides and EGF(A) peptidesNOVO NORDISK AS·Filed 2019·Granted May 16, 2023·0 cites·14 claims
- 0944US2022184184A1Glucose sensitive insulin derivativesNOVO NORDISK AS·Filed 2020·Application pending·0 cites
- 1041US11471537B2Oligomer extended insulin-Fc conjugatesNOVO NORDISK AS·Filed 2018·Granted Oct 18, 2022·0 cites·19 claims
- 1140US11352406B2Insulin derivatives and the medical uses hereofNOVO NORDISK AS·Filed 2016·Granted Jun 7, 2022·0 cites·8 claims
- 1239US2018244743A1Novel Insulin Derivatives and the Medical Uses HereofNOVO NORDISK AS·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →